Financials
- Market Capitalization 84.19 M
- Employee 9
- Founded 2018
- CEO N/A
- Website www.rallybio.com
- Headquarter Delaware, United States
- FIGI BBG011PFKF54
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4055 | NRXS Neuraxis, Inc. Common Stock | 6.88 USD | -3.64% | -7.28% | -1.15% | +26.70% | 85.20 M USD | ||
| 4057 | ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.98 USD | +1.02% | +9.39% | +27.74% | +48.87% | 84.75 M USD | ||
| 4086 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.64 USD | -1.20% | -4.65% | +31.20% | -7.34% | 80.73 M USD | ||
| 4087 | CSBR Champions Oncology, Inc. - Common Stock | 5.81 USD | -0.17% | +1.40% | -10.48% | -27.83% | 80.68 M USD |
Frequently asked questions about Rallybio Corporation - Common Stock
What is the Rallybio Corporation - Common Stock stock price today?
The current price of Rallybio Corporation - Common Stock (RLYB) is 15.89. Over the past 24 hours, the stock has changed by +1.02%. Follow the RLYB chart for real-time price dynamics.
What is the stock ticker of Rallybio Corporation - Common Stock?
Rallybio Corporation - Common Stock trades under the ticker RLYB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rallybio Corporation - Common Stock stock going up?
RLYB has changed by +0.19% over the last week, -0.50% over the last month, and +3431.11% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Rallybio Corporation - Common Stock net income for the last quarter?
Rallybio Corporation - Common Stock reported net income of -8.28 M for the last quarter. The previous quarter showed -5.85 M, which means net income changed by -41.46%.
How many employees does Rallybio Corporation - Common Stock have?
As of the latest available data, Rallybio Corporation - Common Stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.
What is Rallybio Corporation - Common Stock EBITDA?
Rallybio Corporation - Common Stock EBITDA is -8.78 M, and its EBITDA margin is -4 143.4%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Rallybio Corporation - Common Stock stock?
You can buy Rallybio Corporation - Common Stock (RLYB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rallybio Corporation - Common Stock stock?
Investing in Rallybio Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RLYB chart and related analysis on metatrader.com as part of your research.